There are currently nine approved disease modifying therapies for relapsing forms of multiple sclerosis, with six distinct mechanisms of action. All have side effects, and none are cures. When a patient cannot tolerate therapy, or there is unacceptable breakthrough disease activity, the most common approach is to change drug. No universal guidelines exist for switching therapy. This overview will propose switch principles and suggestions.
机构:
Univ South China, Hengyang Med Sch, Hengyang City 421001, Hunan, Peoples R ChinaUniv South China, Hengyang Med Sch, Hengyang City 421001, Hunan, Peoples R China
Li, Hui
Lian, Gaojian
论文数: 0引用数: 0
h-index: 0
机构:
Univ South China, Hengyang Med Sch, Hengyang City 421001, Hunan, Peoples R ChinaUniv South China, Hengyang Med Sch, Hengyang City 421001, Hunan, Peoples R China
Lian, Gaojian
Wang, Guang
论文数: 0引用数: 0
h-index: 0
机构:
Univ South China, Hengyang Med Sch, Hengyang City 421001, Hunan, Peoples R ChinaUniv South China, Hengyang Med Sch, Hengyang City 421001, Hunan, Peoples R China
Wang, Guang
Yin, Qianmei
论文数: 0引用数: 0
h-index: 0
机构:
Univ South China, Hengyang Med Sch, Hengyang City 421001, Hunan, Peoples R ChinaUniv South China, Hengyang Med Sch, Hengyang City 421001, Hunan, Peoples R China
Yin, Qianmei
Su, Zehong
论文数: 0引用数: 0
h-index: 0
机构:
Univ South China, Hengyang Med Sch, Hengyang City 421001, Hunan, Peoples R ChinaUniv South China, Hengyang Med Sch, Hengyang City 421001, Hunan, Peoples R China